Tag Archives: Arena Pharmaceuticals

Brazil: ANVISA bans Lorcaserin (Belviq)

Today ANVISA, the Brazilian health authority with competence on the control of pharmaceutical products and APIs, banned the manufacturing, import, commercialization, manipulation and use of the API Lorcaserin. Lorcaserin is the drug substance of Belviq, an innovative weight-loss product that … Continue reading

Posted in Brazil | Tagged , , , , , , , , , , , , | 3 Comments